Table 1 Baseline demographic and clinical characteristics of the study population*
Baseline characteristics | Value |
|---|---|
N | 626 |
Age at transplant (years) | 48 ± 11 (18 to 77) |
Recipients older than 65 years | 40 (6.3%) |
Male gender | 380 (60.7%) |
Cause of end-stage kidney disease: | |
• Glomerulonephritis | 196 (31.3%) |
• ADPKD | 97 (15.5%) |
• Diabetes mellitus | 47 (7.5%) |
• (DM type 1) | 23 |
• (DM type 2) | 24 |
• Arterial hypertension | 45 (7.2%) |
• Vesicoureteral reflux | 26 (4.1%) |
• Pyelonephritis | 25 (4%) |
• FSGS | 18 (2.9%) |
• Alport syndrome | 16 (2.5%) |
• Other | 156 (25%) |
Graft type: | |
• deceased donor | 624 (99.7%) |
• living related donor | 2 (0.3%) |
Concurrent other organ transplantation | 14 (2.2%) |
Time from AVF construction to transplant (months) | 66 ± 49 (2 to 326) |
AVF site | |
• forearm | 521 (83.2%) |
• upper arm | 105 (16.8%) |
AVF nature | |
• native | 605 (96.7%) |
• PTFE graft | 21 (3.3%) |
Delayed graft function | 145 (23.1%) |